Alphadyne Asset Management »

Intellia Therapeutics shares owned by Alphadyne Asset Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Alphadyne Asset Management from 13F filings

Historical chart of Alphadyne Asset Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Alphadyne Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Alphadyne Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $131k 10k 12.82

More positions owned by Alphadyne Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Exxon Mobil Corporation Call Option (XOM)
Johnson & Johnson Call Option (JNJ)
FedEx Corporation (FDX)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Amazon (AMZN)
Meta Platforms Cl A (META)
CF Industries Holdings (CF)
Merck & Co Call Option (MRK)
Alphabet Cap Stk Cl A (GOOGL)
Target Corporation Call Option (TGT)
Raytheon Technologies Corp (RTX)
NVIDIA Corporation (NVDA)
Amgen (AMGN)

View all positions for Alphadyne Asset Management

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
State Street Corporation
Vanguard Portfolio Management
D. E. Shaw & Co
Vanguard Capital Management
Two Sigma Investments
Regeneron Pharmaceuticals
UBS Group
Geode Capital Management
Susquehanna International
Dimensional Fund Advisors
Morgan Stanley
FMR
Sumitomo Mitsui Trust Holdings

View all funds holding Intellia Therapeutics